{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:03:38Z","timestamp":1794535418593,"version":"4.9.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Malignant pleural mesothelioma (MPM) is a rare and aggressive carcinoma located in pleural cavity. Due to lack of effective diagnostic biomarkers and therapeutic targets in MPM, the prognosis is extremely poor. Because of difficulties in sample extraction, and the high rate of misdiagnosis, MPM is rarely studied. Therefore, novel modeling methodology is crucially needed to facilitate MPM research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A novel patient-derived xenograft (PDX) modeling strategy was designed, which included preliminary screening of patients with pleural thickening using computerized tomography (CT) scan, further reviewing history of disease and imaging by a senior sonographer as well as histopathological analysis by a senior pathologist, and PDX model construction using ultrasound-guided pleural biopsy from MPM patients. Gas chromatography-mass spectrometry-based metabolomics was further utilized for investigating circulating metabolic features of the PDX models. Univariate and multivariate analysis, and pathway analysis were performed to explore the differential metabolites, enriched metabolism pathways and potential metabolic targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After screening using our strategy, 5 out of 116 patients were confirmed to be MPM, and their specimens were used for modeling. Two PDX models were established successfully. Metabolomics analysis revealed significant metabolic shifts in PDX models, such as dysregulations in amino acid metabolism, TCA cycle and glycolysis, and nucleotide metabolism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>To sum up, we suggested a novel modeling strategy that may facilitate specimen availability for MM research, and by applying metabolomics in this model, several metabolic features were identified, whereas future studies with large sample size are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-021-08980-5","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T10:02:48Z","timestamp":1637143368000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A novel PDX modeling strategy and its application in metabolomics study for malignant pleural mesothelioma"],"prefix":"10.1186","volume":"21","author":[{"given":"Zhongjian","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,17]]},"reference":[{"issue":"4","key":"8980_CR1","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1001\/jamaoncol.2016.5487","volume":"3","author":"W Mao","year":"2017","unstructured":"Mao W, Zhang X, Guo Z, Gao Z, Pass HI, Yang H, et al. Association of asbestos exposure with malignant mesothelioma incidence in eastern China. JAMA Oncol. 2017;3(4):562\u20134. https:\/\/doi.org\/10.1001\/jamaoncol.2016.5487.","journal-title":"JAMA Oncol"},{"issue":"2","key":"8980_CR2","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.lungcan.2013.11.026","volume":"83","author":"C Cao","year":"2014","unstructured":"Cao C, Tian D, Park J, Allan J, Pataky KA, Yan TD. A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma. Lung Cancer. 2014;83(2):240\u20135. https:\/\/doi.org\/10.1016\/j.lungcan.2013.11.026.","journal-title":"Lung Cancer"},{"issue":"7","key":"8980_CR3","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.jtho.2017.04.002","volume":"12","author":"B Liu","year":"2017","unstructured":"Liu B, Van Gerwen M, Bonassi S, Taioli E. Epidemiology of environmental exposure and malignant mesothelioma. J Thorac Oncol. 2017;12(7):1031\u201345. https:\/\/doi.org\/10.1016\/j.jtho.2017.04.002.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"8980_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12890-021-01513-7","volume":"21","author":"SG Gray","year":"2021","unstructured":"Gray SG. Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma. BMC Pulm Med. 2021;21(1):1\u201324. https:\/\/doi.org\/10.1186\/s12890-021-01513-7.","journal-title":"BMC Pulm Med"},{"issue":"26","key":"8980_CR5","doi-asserted-by":"publisher","first-page":"3840","DOI":"10.1002\/sim.8697","volume":"39","author":"O Petrof","year":"2020","unstructured":"Petrof O, Neyens T, Nuyts V, Nackaerts K, Nemery B, Faes C. On the impact of residential history in the spatial analysis of diseases with a long latency period: a study of mesothelioma in Belgium. Stat Med. 2020;39(26):3840\u201366. https:\/\/doi.org\/10.1002\/sim.8697.","journal-title":"Stat Med"},{"issue":"4","key":"8980_CR6","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.jtho.2016.12.006","volume":"12","author":"Z Guo","year":"2017","unstructured":"Guo Z, Carbone M, Zhang X, Su D, Sun W, Lou J, et al. Improving the accuracy of mesothelioma diagnosis in China. J Thorac Oncol. 2017;12(4):714\u201323. https:\/\/doi.org\/10.1016\/j.jtho.2016.12.006.","journal-title":"J Thorac Oncol"},{"issue":"12","key":"8980_CR7","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.3390\/cancers12123846","volume":"12","author":"R Affatato","year":"2020","unstructured":"Affatato R, Mendogni P, Del Gobbo A, Ferrero S, Ricci F, Broggini M, et al. Establishment and characterization of patient-derived xenografts (PDXs) of different histology from malignant pleural mesothelioma patients. Cancers. 2020;12(12):3846. https:\/\/doi.org\/10.3390\/cancers12123846.","journal-title":"Cancers"},{"issue":"4","key":"8980_CR8","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1158\/1078-0432.CCR-16-0844","volume":"23","author":"L Wu","year":"2017","unstructured":"Wu L, Allo G, John T, Li M, Tagawa T, Opitz I, et al. Patient-derived xenograft establishment from human malignant pleural mesothelioma. Clin Cancer Res. 2017;23(4):1060\u20137. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-0844.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"8980_CR9","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1148\/radiol.12112077","volume":"266","author":"LM Sconfienza","year":"2013","unstructured":"Sconfienza LM, Mauri G, Grossi F, Truini M, Serafini G, Sardanelli F, et al. Pleural and peripheral lung lesions: comparison of US-and CT-guided biopsy. Radiology. 2013;266(3):930\u20135. https:\/\/doi.org\/10.1148\/radiol.12112077.","journal-title":"Radiology."},{"issue":"8","key":"8980_CR10","doi-asserted-by":"publisher","first-page":"e6554","DOI":"10.1371\/journal.pone.0006554","volume":"4","author":"OD R\u00f8e","year":"2009","unstructured":"R\u00f8e OD, Anderssen E, Helge E, Pettersen CH, Olsen KS, Sandeck H, et al. Genome-wide profile of pleural mesothelioma versus parietal and visceral pleura: the emerging gene portrait of the mesothelioma phenotype. PLoS One. 2009;4(8):e6554. https:\/\/doi.org\/10.1371\/journal.pone.0006554.","journal-title":"PLoS One"},{"issue":"1","key":"8980_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.lungcan.2009.03.016","volume":"67","author":"OD R\u00f8e","year":"2010","unstructured":"R\u00f8e OD, Anderssen E, Sandeck H, Christensen T, Larsson E, Lundgren S. Malignant pleural mesothelioma: genome-wide expression patterns reflecting general resistance mechanisms and a proposal of novel targets. Lung Cancer. 2010;67(1):57\u201368. https:\/\/doi.org\/10.1016\/j.lungcan.2009.03.016.","journal-title":"Lung Cancer"},{"issue":"3","key":"8980_CR12","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/JTO.0000000000000466","volume":"10","author":"M Carbone","year":"2015","unstructured":"Carbone M, Gaudino G, Yang H. Recent insights emerging from malignant mesothelioma genome sequencing. J Thorac Oncol. 2015;10(3):409\u201311. https:\/\/doi.org\/10.1097\/JTO.0000000000000466.","journal-title":"J Thorac Oncol"},{"key":"8980_CR13","doi-asserted-by":"publisher","unstructured":"Fiehn O. Metabolomics\u2014the link between genotypes and phenotypes. Funct Genomics. 2002:155\u201371. https:\/\/doi.org\/10.1007\/978-94-010-0448-0_11.","DOI":"10.1007\/978-94-010-0448-0_11"},{"issue":"10","key":"8980_CR14","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1038\/cdd.2017.95","volume":"24","author":"A Bononi","year":"2017","unstructured":"Bononi A, Yang H, Giorgi C, Patergnani S, Pellegrini L, Su M, et al. Germline BAP1 mutations induce a Warburg effect. Cell Death Differ. 2017;24(10):1694\u2013704. https:\/\/doi.org\/10.1038\/cdd.2017.95.","journal-title":"Cell Death Differ"},{"issue":"10","key":"8980_CR15","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","volume":"20","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Shi J, Liu X, Feng L, Gong Z, Koppula P, et al. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol. 2018;20(10):1181\u201392. https:\/\/doi.org\/10.1038\/s41556-018-0178-0.","journal-title":"Nat Cell Biol"},{"issue":"6","key":"8980_CR16","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.21037\/jtd.2018.05.94","volume":"10","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Tang J, Zhou X, Zhou D, Wang J, Tang Q. Ultrasound-guided pleural cutting needle biopsy: accuracy and factors influencing diagnostic yield. J Thorac Dis. 2018;10(6):3244\u201352. https:\/\/doi.org\/10.21037\/jtd.2018.05.94.","journal-title":"J Thorac Dis"},{"issue":"6","key":"8980_CR17","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1039\/C9EN00137A","volume":"6","author":"L Zhao","year":"2019","unstructured":"Zhao L, Zhang H, White JC, Chen X, Li H, Qu X, et al. Metabolomics reveals that engineered nanomaterial exposure in soil alters both soil rhizosphere metabolite profiles and maize metabolic pathways. Environ Sci Nano. 2019;6(6):1716\u201327. https:\/\/doi.org\/10.1039\/C9EN00137A.","journal-title":"Environ Sci Nano"},{"issue":"3","key":"8980_CR18","doi-asserted-by":"publisher","first-page":"936","DOI":"10.21037\/jtd.2019.01.88","volume":"11","author":"N Yamamoto","year":"2019","unstructured":"Yamamoto N, Watanabe T, Yamada K, Nakai T, Suzumura T, Sakagami K, et al. Efficacy and safety of ultrasound (US) guided percutaneous needle biopsy for peripheral lung or pleural lesion: comparison with computed tomography (CT) guided needle biopsy. J Thorac Dis. 2019;11(3):936\u201343. https:\/\/doi.org\/10.21037\/jtd.2019.01.88.","journal-title":"J Thorac Dis"},{"issue":"1","key":"8980_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4143\/crt.2017.307","volume":"50","author":"J Jung","year":"2018","unstructured":"Jung J, Seol HS, Chang S. The generation and application of patient-derived xenograft model for cancer research. Cancer Res Treat. 2018;50(1):1\u201310. https:\/\/doi.org\/10.4143\/crt.2017.307.","journal-title":"Cancer Res Treat"},{"issue":"15","key":"8980_CR20","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.1158\/0008-5472.CAN-12-4081","volume":"73","author":"X Zhang","year":"2013","unstructured":"Zhang X, Claerhout S, Prat A, Dobrolecki LE, Petrovic I, Lai Q, et al. A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models. Cancer Res. 2013;73(15):4885\u201397. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-4081.","journal-title":"Cancer Res"},{"issue":"11","key":"8980_CR21","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1038\/nprot.2009.171","volume":"4","author":"MP Kim","year":"2009","unstructured":"Kim MP, Evans DB, Wang H, Abbruzzese JL, Fleming JB, Gallick GE. Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice. Nat Protoc. 2009;4(11):1670\u201380. https:\/\/doi.org\/10.1038\/nprot.2009.171.","journal-title":"Nat Protoc"},{"issue":"19","key":"8980_CR22","doi-asserted-by":"publisher","first-page":"5314","DOI":"10.1158\/1078-0432.CCR-12-0372","volume":"18","author":"S Julien","year":"2012","unstructured":"Julien S, Merino-Trigo A, Lacroix L, Pocard M, Go\u00e9r\u00e9 D, Mariani P, et al. Characterization of a large panel of patient-derived tumor xenografts representing the clinical heterogeneity of human colorectal cancer. Clin Cancer Res. 2012;18(19):5314\u201328. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-0372.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"8980_CR23","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1158\/1078-0432.CCR-09-2878","volume":"16","author":"X Dong","year":"2010","unstructured":"Dong X, Guan J, English JC, Flint J, Yee J, Evans K, et al. Patient-derived first generation xenografts of non\u2013small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy. Clin Cancer Res. 2010;16(5):1442\u201351. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-2878.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"8980_CR24","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.31557\/APJCP.2020.21.5.1453","volume":"21","author":"K Bodoor","year":"2020","unstructured":"Bodoor K, Almomani R, Alqudah M, Haddad Y, Samouri W. LAT1 (SLC7A5) overexpression in negative Her2 Group of Breast Cancer: a potential therapy target. Asian Pac J Cancer Prev. 2020;21(5):1453\u20138. https:\/\/doi.org\/10.31557\/APJCP.2020.21.5.1453.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"8980_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41588-020-00753-3","volume":"53","author":"AK Najumudeen","year":"2021","unstructured":"Najumudeen AK, Ceteci F, Fey SK, Hamm G, Steven RT, Hall H, et al. The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer. Nat Genet. 2021;53(1):16\u201326. https:\/\/doi.org\/10.1038\/s41588-020-00753-3.","journal-title":"Nat Genet"},{"issue":"4","key":"8980_CR26","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.3390\/ijms21041407","volume":"21","author":"LH Alfarsi","year":"2020","unstructured":"Alfarsi LH, El-Ansari R, Craze ML, Masisi BK, Mohammed OJ, Ellis IO, et al. Co-Expression Effect of SLC7A5\/SLC3A2 to Predict Response to Endocrine Therapy in Oestrogen-Receptor-Positive Breast Cancer. Int J Mol Sci. 2020;21(4):1407. https:\/\/doi.org\/10.3390\/ijms21041407.","journal-title":"Int J Mol Sci."},{"issue":"3","key":"8980_CR27","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1158\/1055-9965.EPI-13-0770","volume":"23","author":"SC Chuang","year":"2014","unstructured":"Chuang SC, Fanidi A, Ueland PM, Relton C, Midttun O, Vollset SE, et al. Circulating biomarkers of tryptophan and the kynurenine pathway and lung cancer risk. Cancer Epidemiol Biomark Prev. 2014;23(3):461\u20138. https:\/\/doi.org\/10.1158\/1055-9965.EPI-13-0770.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"8980_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/bs.ircmb.2017.07.004","volume":"336","author":"GC Prendergast","year":"2018","unstructured":"Prendergast GC, Malachowski WJ, Mondal A, Scherle P, Muller AJ. Indoleamine 2,3-dioxygenase and its therapeutic inhibition in Cancer. Int Rev Cell Mol Biol. 2018;336:175\u2013203. https:\/\/doi.org\/10.1016\/bs.ircmb.2017.07.004.","journal-title":"Int Rev Cell Mol Biol"},{"issue":"12","key":"8980_CR29","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.7150\/jca.31727","volume":"10","author":"Z Ye","year":"2019","unstructured":"Ye Z, Yue L, Shi J, Shao M, Wu T. Role of IDO and TDO in cancers and related diseases and the therapeutic implications. J Cancer. 2019;10(12):2771\u201382. https:\/\/doi.org\/10.7150\/jca.31727.","journal-title":"J Cancer"},{"key":"8980_CR30","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.3389\/fimmu.2020.01185","volume":"11","author":"L Zhai","year":"2020","unstructured":"Zhai L, Bell A, Ladomersky E, Lauing KL, Bollu L, Sosman JA, et al. Immunosuppressive IDO in Cancer: mechanisms of action, animal models, and targeting strategies. Front Immunol. 2020;11:1185. https:\/\/doi.org\/10.3389\/fimmu.2020.01185.","journal-title":"Front Immunol"},{"issue":"4","key":"8980_CR31","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/path.4218","volume":"230","author":"SYC Choi","year":"2013","unstructured":"Choi SYC, Collins CC, Gout PW, Wang Y. Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite? J Pathol. 2013;230(4):350\u20135. https:\/\/doi.org\/10.1002\/path.4218.","journal-title":"J Pathol"},{"issue":"21","key":"8980_CR32","doi-asserted-by":"publisher","first-page":"eabg6165","DOI":"10.1126\/sciadv.abg6165","volume":"7","author":"Y Ariav","year":"2021","unstructured":"Ariav Y, Ch\u2019ng JH, Christofk HR, Ron-Harel N, Erez A. Targeting nucleotide metabolism as the nexus of viral infections, cancer, and the immune response. Sci Adv. 2021;7(21):eabg6165.","journal-title":"Sci Adv"},{"issue":"15","key":"8980_CR33","doi-asserted-by":"publisher","first-page":"5059","DOI":"10.1158\/0008-5472.CAN-04-1586","volume":"64","author":"D-E Hu","year":"2004","unstructured":"Hu D-E, Moore AM, Thomsen LL, Brindle KM. Uric acid promotes tumor immune rejection. Cancer Res. 2004;64(15):5059\u201362. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-1586.","journal-title":"Cancer Res"},{"key":"8980_CR34","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.cca.2017.08.027","volume":"473","author":"C-F Yue","year":"2017","unstructured":"Yue C-F, Feng P-N, Yao Z-R, Yu X-G, Lin W-b, Qian Y-M, et al. High serum uric acid concentration predicts poor survival in patients with breast cancer. Clin Chim Acta. 2017;473:160\u20135. https:\/\/doi.org\/10.1016\/j.cca.2017.08.027.","journal-title":"Clin Chim Acta"},{"issue":"5","key":"8980_CR35","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00394-007-0665-8","volume":"46","author":"C-c Lin","year":"2007","unstructured":"Lin C-c, M-c Y. B vitamins deficiency and decreased anti-oxidative state in patients with liver cancer. Eur J Nutr. 2007;46(5):293\u20139. https:\/\/doi.org\/10.1007\/s00394-007-0665-8.","journal-title":"Eur J Nutr"},{"issue":"9\u201310","key":"8980_CR36","first-page":"795","volume":"57","author":"R Dhankhar","year":"2011","unstructured":"Dhankhar R, Dahiya K, Sharma TK, Ghalaut VS, Atri R, Kaushal V. Diagnostic significance of adenosine deaminase, uric acid and C-reactive protein levels in patients of head and neck carcinoma. Clin Lab. 2011;57(9\u201310):795\u20138.","journal-title":"Clin Lab"},{"issue":"1","key":"8980_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5049\/EBP.2014.12.1.1","volume":"12","author":"D-H Kang","year":"2014","unstructured":"Kang D-H, Ha S-K. Uric acid puzzle: dual role as anti-oxidantand pro-oxidant. Electrolytes Blood Press. 2014;12(1):1\u20136. https:\/\/doi.org\/10.5049\/EBP.2014.12.1.1.","journal-title":"Electrolytes Blood Press"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08980-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08980-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08980-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T10:03:35Z","timestamp":1637143415000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08980-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,17]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8980"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08980-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-624838\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,17]]},"assertion":[{"value":"15 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Collection of human samples was approved by The Ethical Committee of Zhejiang Cancer Hospital (approval number: IRB-2018-9); the animal experiment was permitted by the Institutional Animal Care and Ethics Committee of Zhejiang Cancer Hospital (No. 2018\u201303-054).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1235"}}